[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Regeneron Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::23077762.png) @Regeneron Regeneron

Regeneron posts on X about sanofi, breakingnews the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::23077762/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::23077762/c:line/m:interactions.svg)

- X Week XXXXX +14%
- X Month XXXXX -XX%
- X Months XXXXXX +54%
- X Year XXXXXX +502%

### Mentions: X [#](/creator/twitter::23077762/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::23077762/c:line/m:posts_active.svg)

- X Week X -XX%
- X Month XX -XX%
- X Months XX +288%
- X Year XX +179%

### Followers: XXXXXX [#](/creator/twitter::23077762/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::23077762/c:line/m:followers.svg)

- X Week XXXXXX +0.03%
- X Month XXXXXX +0.05%
- X Months XXXXXX +1.10%
- X Year XXXXXX +0.69%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::23077762/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::23077762/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks) 

**Social topic influence**
[sanofi](/topic/sanofi) #28, [breakingnews](/topic/breakingnews)

**Top accounts mentioned or mentioned by**
[@mikej_ha_ha](/creator/undefined) [@grok](/creator/undefined) [@sanofi](/creator/undefined) [@pitchdecks](/creator/undefined) [@scifest4stem](/creator/undefined) [@stock6996](/creator/undefined) [@who](/creator/undefined) [@megtirrell](/creator/undefined) [@paulbiogeek](/creator/undefined) [@nejm](/creator/undefined) [@galienfdn](/creator/undefined) [@tesseratx](/creator/undefined) [@nikatabhishek](/creator/undefined) [@bicep_crypto](/creator/undefined) [@checkorphan](/creator/undefined) [@deryatr_](/creator/undefined) [@peerview](/creator/undefined) [@pietjepsvpuk](/creator/undefined) [@ebsummiteurope](/creator/undefined) [@twagner85](/creator/undefined)

**Top assets mentioned**
[Sanofi (SNY)](/topic/sanofi)
### Top Social Posts
Top posts by engagements in the last XX hours

"We are pleased to announce that the U.S. FDA has approved our medicine for the treatment of macular edema following retinal vein occlusion (RVO) and a monthly dosing option in all approved indications"  
[X Link](https://x.com/Regeneron/status/1991266938933375121)  2025-11-19T22:06Z 33.5K followers, 1931 engagements


"At #ASH25 we're presenting new and updated data from our hematology portfolio and pipeline. Learn more about how this will highlight the next wave of potential novel approaches across a range of blood cancers and disorders"  
[X Link](https://x.com/Regeneron/status/1988941781300641962)  2025-11-13T12:07Z 33.5K followers, XXX engagements


"At #ACAAI25 were presenting results from our Phase X trial in allergic fungal rhinosinusitis (AFRS) in people aged X and older. These pivotal data also support the sBLA that was recently accepted for Priority Review by the FDA. Learn more: CC: @sanofi"  
[X Link](https://x.com/Regeneron/status/1986794183546327465)  2025-11-07T13:53Z 33.5K followers, 1255 engagements


"Phase X data on our novel investigational factor XI antibodies were published in @TheLancet and presented at the @American_Heart Scientific Sessions. Read more: #AHA25"  
[X Link](https://x.com/Regeneron/status/1987187923389698067)  2025-11-08T15:58Z 33.5K followers, 1194 engagements


"#BreakingNews: The European Commission (EC) has approved our medicine as an adjuvant treatment for adults with cutaneous squamous cell carcinoma (#CSCC) with high risk of disease recurrence after surgery and radiation"  
[X Link](https://x.com/Regeneron/status/1991116303613247569)  2025-11-19T12:08Z 33.5K followers, 1091 engagements


"Were pleased to share that the European Commission has approved our medicine for the treatment of #ChronicSpontaneousUrticaria (CSU) in certain adults and adolescents aged 12+ in the EU. CC: @Sanofi"  
[X Link](https://x.com/Regeneron/status/1993288667553841384)  2025-11-25T12:00Z 33.5K followers, XXX engagements


"#BreakingNews: Were excited to collaborate with @TesseraTx to combine our strengths in genetics and genetic medicines with Tesseras Gene Writing genome engineering technology"  
[X Link](https://x.com/Regeneron/status/1995465453557182580)  2025-12-01T12:10Z 33.5K followers, 2139 engagements


"Today at #ASH25 we presented new data investigating our bispecific therapy in newly diagnosed #multiplemyeloma. Learn more about the latest results. Read more:"  
[X Link](https://x.com/Regeneron/status/1997782124821180481)  2025-12-07T21:35Z 33.5K followers, 1386 engagements